Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Participants With Solid Tumors
Clinical trial NCT01190644 · TERMINATED
Trial details
- NCT number
- NCT01190644
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2012-09-18
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.